Intrinsiqq
Cel-Sci Corporation logo

Cel-Sci Corporation Quality Score

CVM

⊜ Compare
Quality0

Weak across most dimensions. This doesn't mean avoid, but the burden of proof is on the bull case.

Broad-market heuristics · Not a buy/sell signal

Valuation and growth

Earnings Multiple
0/100
-1.2x

Negative earnings, no valuation support

Cash Flow Multiple
0/100
-1.4x

Negative FCF, no valuation support

Revenue Growth
0/100
-34.9%

Below 2%, essentially flat

Cash Flow Growth
0/100
Negative FCF

FCF negative, burning cash after capex

Business Quality & Capital Allocation

Share Dilution
0/100
43486.4%

Heavy dilution above 5%

Margin Trend
0/100
-7840.4pp

Contracted >2pp, margin pressure

Capital Structure
0/100
$1M

Positive debt with no FCF to service it

2011
$4.00M
$5.00M
2012
$4.00M
$0.00
2013
$41612
$29137
2014
$9.00M
$17523
TTM
$7.00M
$8.00M
CashDebt
Return on Capital
0/100
-80.2%

Below 8%, may not cover cost of capital

Customize WeightsPremiumUpgrade

Cel-Sci (CVM) quality: score, margins and returns

Cel-Sci (CVM) scores 0/100 on Intrinsiqq's quality score (a lower-quality business), a weighted blend of 6 metrics each scored 0 to 100 and -80.2% ROIC. Every metric is computed from SEC filings; this is analysis, not investment advice.

Frequently asked

Is Cel-Sci (CVM) a high-quality business?+

Cel-Sci scores 0 out of 100 on Intrinsiqq's quality score, a weighted blend of 6 metrics each scored 0 to 100, which rates it a lower-quality business on these measures. Recent figures include a -80.2% return on invested capital. Quality and price are separate questions: even a great business can be a poor investment if you overpay, so read this score alongside the valuation. The metric-by-metric breakdown is on this scorecard.

What does Cel-Sci's quality score measure?+

Intrinsiqq's quality score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, change in share count, and balance-sheet strength, each computed from CVM's SEC filings rather than opinion or sentiment. A higher score means a more durable, capital-efficient business; it is not a buy or sell signal. Open each metric on this page to see exactly where Cel-Sci scores well and where it falls behind.

What is Cel-Sci's return on invested capital (ROIC)?+

Cel-Sci earns about -80.2% on its invested capital, which is weak. ROIC measures how much profit a company generates per dollar put to work; sustained ROIC above its cost of capital is one of the clearest signs of a real competitive moat. Compare it to CVM's margins and growth on this scorecard to judge durability.

How the market compares: US profitability statistics

SourceQuality score computed from the 10-Q filed 10 Aug 2026, covering the period ending 30 Jun 2026, as reported to the SEC. Data last refreshed 12 Oct 2026. How this is calculated.

Fiscal year ends Sep. Sector medians are approximate S&P 500 benchmarks and update periodically. Checks use broad-market heuristics, so sector norms may differ, and the valuation checks are more cyclical than the quality checks.

Peers

Biological Products, (No Diagnostic Substances) · Pick stocks to compare with CVM

CompareIntrinsic value
BCABBioAtla, Inc.
$2.00+0.00%0
ZIVOZivo Bioscience Inc.
$8.00+10.34%0
WINTWindtree Therapeutics Inc.
$0.00+0.00%10
ATYRAtyr Pharma Inc.
$6.18-6.79%10
ARMPArmata Pharmaceuticals Inc.
$3.14+1.62%30
VIVSVivoSim Labs, Inc.
$0.15+8.71%10
AIMAIM ImmunoTech Inc.
$0.16+0.63%15
INMBInmune Bio Inc.
$1.33+0.76%10

Spot a number that looks wrong? Check it in CVM's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing CVM

Create a free account and get 14 days of Premium: every stock and every tool.

  • Unlimited stocks
  • Stock screener
  • Portfolio tracker
  • Editable DCF
  • Compare side by side
  • Unlimited alerts

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.